NextCure, Inc.NXTCNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
5Y CAGR-62.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-62.1%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$365000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$46.55M+36.1%
2019$34.22M+1940.3%
2018$1.68M+188.1%
2017$582000.00-